APA (7th ed.) Citation

Pinter, M., Sieghart, W., Hucke, F., Graziadei, I., Vogel, W., Maieron, A., . . . Peck‐Radosavljevic, M. (2011). Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. Alimentary Pharmacology & Therapeutics, 34(8), 949. https://doi.org/10.1111/j.1365-2036.2011.04823.x

Chicago Style (17th ed.) Citation

Pinter, M., et al. "Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib." Alimentary Pharmacology & Therapeutics 34, no. 8 (2011): 949. https://doi.org/10.1111/j.1365-2036.2011.04823.x.

MLA (9th ed.) Citation

Pinter, M., et al. "Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib." Alimentary Pharmacology & Therapeutics, vol. 34, no. 8, 2011, p. 949, https://doi.org/10.1111/j.1365-2036.2011.04823.x.